Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 14
Commentary
CheckMate-722: The Rise and Fall of Nivolumab with Chemotherapy in TKI-Refractory EGFR-Mutant NSCLC
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,362 | Dovepress* | 3,182+ | 96 | 3,278 | |
| PubMed Central* | 2,180 | 520 | 2,700 | ||
| Totals | 5,362 | 616 | 5,978 | ||
| *Since 25 April 2023 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 5 | 0 | 0 | 1 | 1 | 3 |
View citations on PubMed Central and Google Scholar